Back to search
Pigmented Lesions
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pigmented Lesions trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pigmented Lesions trials you may qualify forThis observational, prospective cohort study aims to evaluate the diagnostic relevance of Reflectance Confocal Microscopy (RCM) features in atypical melanocytic…
This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or…
The incidence of skin cancer has been continuously increasing over the past decades und the number of non melanoma skin cancer is well as melanoma is still goin…
The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias. Since then, i…
This study aims to determine if an artificial intelligence (AI) medical device can help primary care doctors more accurately identify and manage various skin co…
The aim of this study is to evaluate the imaging performance of Spectrally Encoded Confocal Microscopy (SECM) for imaging human skin and skin diseases.
The purpose of this research is to develop non-invasive imaging modalities for assessment of skin. This is a pilot study which will use multiple imaging modalit…